Research Analysts Issue Forecasts for Celsius Q4 Earnings

Celsius Holdings, Inc. (NASDAQ:CELHFree Report) – Equities researchers at William Blair upped their Q4 2024 earnings estimates for Celsius in a report released on Wednesday, November 6th. William Blair analyst J. Andersen now expects that the company will earn $0.15 per share for the quarter, up from their previous forecast of $0.12. The consensus estimate for Celsius’ current full-year earnings is $0.70 per share. William Blair also issued estimates for Celsius’ FY2025 earnings at $0.85 EPS.

CELH has been the subject of several other research reports. LADENBURG THALM/SH SH lowered their price objective on Celsius from $72.00 to $68.00 and set a “neutral” rating for the company in a research report on Monday, October 21st. Roth Mkm dropped their price target on shares of Celsius from $43.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday, November 7th. TD Cowen decreased their price objective on shares of Celsius from $68.00 to $50.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Truist Financial increased their price objective on Celsius from $30.00 to $35.00 and gave the stock a “hold” rating in a report on Wednesday, October 16th. Finally, Morgan Stanley reissued an “equal weight” rating and set a $50.00 target price on shares of Celsius in a research note on Tuesday, August 20th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, Celsius presently has a consensus rating of “Moderate Buy” and a consensus target price of $54.40.

View Our Latest Stock Report on Celsius

Celsius Trading Down 1.6 %

NASDAQ CELH opened at $26.96 on Monday. The stock has a 50-day moving average of $31.94 and a 200-day moving average of $50.61. Celsius has a 1-year low of $25.77 and a 1-year high of $99.62. The firm has a market cap of $6.34 billion, a PE ratio of 37.44, a price-to-earnings-growth ratio of 2.52 and a beta of 1.86.

Insider Transactions at Celsius

In other Celsius news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the transaction, the chief executive officer now owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.

Institutional Trading of Celsius

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CELH. S.A. Mason LLC acquired a new stake in shares of Celsius during the second quarter worth about $30,000. EverSource Wealth Advisors LLC lifted its stake in Celsius by 3,116.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock valued at $32,000 after acquiring an additional 374 shares during the period. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in shares of Celsius in the 3rd quarter valued at $34,000. Signaturefd LLC increased its stake in shares of Celsius by 48.3% in the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock worth $36,000 after acquiring an additional 378 shares during the period. Finally, Benjamin F. Edwards & Company Inc. lifted its position in Celsius by 353.1% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock valued at $37,000 after purchasing an additional 505 shares during the period. Institutional investors and hedge funds own 60.95% of the company’s stock.

About Celsius

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Articles

Earnings History and Estimates for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.